Sato-Akushichi Miki, Ono Shinji, Klose Gerd, Song Youngseok
Department of Ophthalmology, Asahikawa Medical University, Asahikawa 078-8510, Japan.
Carl Zeiss Meditec, Inc., Dublin, CA 94568, USA.
Pharmaceuticals (Basel). 2021 Nov 10;14(11):1140. doi: 10.3390/ph14111140.
To evaluate choroidal volume and thickness changes after photodynamic therapy (PDT) for chronic central serous chorioretinopathy (CSC). Chronic CSC eyes with a history of PDT were selected. Average choroidal volume, average choroidal thickness, the maximum and minimum choroidal thickness of the macula irradiated area and peripheral non-irradiated areas before and after one and three months of treatment were examined. A total of 14 patients with chronic CSC and 9 controls without any eye pathology were enrolled. The mean choroidal volume in CSC before and, and after one and three months of treatment were 2.36 (standard deviation: 0.70), 1.90 (0.69), 1.86 (0.66) mm for the central area, 1.25 (0.38), 1.14 (0.35), 1.13 (0.34) mm for superior nasal area, 1.47 (0.41), 1.28 (0.43), 1.26 (0.43) mm for superior temporal area, 1.07 (0.49), 0.95 (0.38), 0.93 (0.35) mm for inferior nasal area, 1.17 (0.38), 1.04 (0.32), 1.03 (0.33) mm for inferior temporal area. This study revealed the choroidal volume changes in a short period after PDT and a decrease in unirradiated choroidal volume was also shown after the treatment. The algorithm provided on the ARI Network enables to evaluate the choroidal changes quantitatively and qualitatively.
评估光动力疗法(PDT)治疗慢性中心性浆液性脉络膜视网膜病变(CSC)后脉络膜体积和厚度的变化。选择有PDT治疗史的慢性CSC患眼。检测治疗前、治疗1个月和3个月后黄斑照射区及周边未照射区的平均脉络膜体积、平均脉络膜厚度、脉络膜最大厚度和最小厚度。共纳入14例慢性CSC患者和9例无眼部病变的对照者。CSC患者治疗前、治疗1个月和3个月后中心区的平均脉络膜体积分别为2.36(标准差:0.70)、1.90(0.69)、1.86(0.66)mm,鼻上区分别为1.25(0.38)、1.14(0.35)、1.13(0.34)mm,颞上区分别为1.47(0.41)、1.28(0.43)、1.26(0.43)mm,鼻下区分别为1.07(0.49)、0.95(0.38)、0.93(0.35)mm,颞下区分别为1.17(0.38)、1.04(0.32)、1.03(0.33)mm。本研究揭示了PDT后短期内脉络膜体积的变化,且治疗后未照射的脉络膜体积也出现下降。ARI网络提供的算法能够对脉络膜变化进行定量和定性评估。